LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $18,275,000 | +11.1% | 133,460 | +10.5% | 0.38% | +7.0% |
| Q3 2017 | $16,450,000 | -0.8% | 120,820 | -11.6% | 0.36% | +1.1% |
| Q2 2017 | $16,586,000 | +26.4% | 136,620 | +10.2% | 0.35% | +24.4% |
| Q1 2017 | $13,123,000 | +59.3% | 123,985 | +53.0% | 0.28% | +52.2% |
| Q4 2016 | $8,236,000 | +21.7% | 81,055 | +22.3% | 0.19% | +44.2% |
| Q3 2016 | $6,765,000 | -14.4% | 66,285 | 0.0% | 0.13% | -17.8% |
| Q2 2016 | $7,906,000 | +17.1% | 66,285 | +5.1% | 0.16% | +17.2% |
| Q1 2016 | $6,753,000 | -1.4% | 63,055 | -0.2% | 0.13% | +2.3% |
| Q4 2015 | $6,851,000 | +31.4% | 63,190 | +3.8% | 0.13% | +23.6% |
| Q3 2015 | $5,215,000 | -5.5% | 60,890 | +11.4% | 0.11% | +7.1% |
| Q2 2015 | $5,516,000 | – | 54,670 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |